What is Anifrolumab: Uses, Dosage, Side Effects and More

Anifrolumab is a targeted medication that helps control systemic lupus erythematosus (SLE), a condition where your immune system mistakenly attacks healthy tissues. This prescription medicine works by blocking specific proteins that fuel inflammation in lupus patients.

If you or someone you care about has been diagnosed with lupus, you might feel overwhelmed by treatment options. Anifrolumab represents a newer approach to managing this complex autoimmune condition, offering hope for better symptom control when other treatments haven't provided enough relief.

What is Anifrolumab?

Anifrolumab is a monoclonal antibody specifically designed to treat moderate to severe systemic lupus erythematosus. It belongs to a class of medications called type I interferon receptor antagonists, which sounds complex but simply means it blocks certain immune system signals that cause inflammation.

Think of your immune system like an overly sensitive alarm system in lupus. Anifrolumab helps turn down the volume on that alarm, reducing the inflammatory response that damages your organs and tissues. This targeted approach differs from older lupus treatments that suppress the entire immune system.

The medication comes as an intravenous infusion, meaning it's given directly into your bloodstream through a small tube in your arm. This method ensures the medicine reaches your system quickly and effectively.

What is Anifrolumab Used For?

Anifrolumab is specifically approved for treating moderate to severe systemic lupus erythematosus in adults. Your doctor might recommend this medication when your lupus symptoms continue despite trying standard treatments like antimalarials or corticosteroids.

The medication helps manage various lupus symptoms that can significantly impact your daily life. These include joint pain and swelling, skin rashes, fatigue, and organ involvement. Many patients find their overall disease activity decreases, allowing them to feel more like themselves again.

Your healthcare provider will typically consider anifrolumab when you have active lupus that affects multiple body systems. This might include kidney involvement, severe skin manifestations, or persistent joint inflammation that interferes with your quality of life.

How Does Anifrolumab Work?

Anifrolumab works by blocking type I interferons, which are proteins your immune system produces in excess when you have lupus. These interferons act like gasoline on a fire, making inflammation worse throughout your body.

When you have lupus, your body produces too many of these inflammatory signals, causing your immune system to attack healthy tissues. Anifrolumab essentially acts like a shield, preventing these harmful signals from reaching their targets and reducing the inflammatory cascade.

This medication is considered moderately strong in the lupus treatment arsenal. It's more targeted than broad immunosuppressants like methotrexate, but it's also more potent than antimalarials like hydroxychloroquine. This makes it a valuable middle-ground option for many patients.

How Should I Take Anifrolumab?

Anifrolumab is given as an intravenous infusion in a healthcare setting, typically a hospital or infusion center. You cannot take this medication at home, as it requires professional monitoring during administration.

The infusion process usually takes about 30 minutes, and you'll receive treatment every four weeks. Your healthcare team will monitor you closely during each infusion to ensure you're tolerating the medication well. Most patients find the process comfortable and use the time to read, listen to music, or simply relax.

You don't need to follow specific dietary restrictions before your infusion, but staying well-hydrated can help you feel more comfortable. Some patients prefer to eat a light meal beforehand to prevent any queasiness, though this isn't typically necessary.

Your medical team will likely pre-medicate you with antihistamines or other medications to prevent infusion reactions. This is a standard precaution and helps ensure your treatment goes smoothly.

How Long Should I Take Anifrolumab For?

The duration of anifrolumab treatment varies significantly from person to person, depending on how well you respond and how your lupus progresses. Many patients continue treatment for months or even years to maintain symptom control.

Your doctor will regularly assess your response to treatment, typically every three to six months. They'll look at laboratory tests, physical symptoms, and your overall quality of life to determine if the medication continues to benefit you.

Some patients notice improvement within the first few months, while others may need six months or longer to experience significant benefits. Lupus is a complex condition, and finding the right treatment timeline requires patience and ongoing communication with your healthcare team.

If you experience excellent symptom control, your doctor might eventually discuss spacing out treatments or exploring other options. However, many patients find that continuing regular infusions provides the most consistent relief from their lupus symptoms.

What Are the Side Effects of Anifrolumab?

Like all medications, anifrolumab can cause side effects, though many patients tolerate it well. Understanding potential reactions helps you know what to expect and when to contact your healthcare provider.

The most common side effects you might experience include respiratory tract infections, such as colds or bronchitis, since the medication affects your immune system. You might also notice reactions at the infusion site, including redness, swelling, or mild discomfort.

Here are the more frequently reported side effects that patients experience:

• Upper respiratory tract infections (colds, sinus infections)
• Bronchitis or other lung infections
• Infusion site reactions (redness, swelling, pain)
• Headaches or mild fatigue after treatment
• Nausea or digestive upset
• Muscle or joint pain

These common side effects are usually mild and manageable with supportive care. Your healthcare team can provide strategies to minimize discomfort and help you feel more comfortable during treatment.

More serious side effects are less common but require immediate medical attention. These rare but important reactions include severe allergic responses, serious infections, or unusual changes in your blood counts.

Watch for these warning signs that need prompt medical evaluation:

• Difficulty breathing or swallowing during or after infusion
• Severe rash, hives, or facial swelling
• Signs of serious infection (high fever, persistent cough, severe fatigue)
• Unusual bleeding or bruising
• Severe abdominal pain or persistent vomiting

Remember that your healthcare team monitors you carefully during each infusion specifically to catch and address any concerning reactions quickly. Most patients complete their treatment courses without experiencing serious side effects.

Who Should Not Take Anifrolumab?

Anifrolumab isn't suitable for everyone with lupus, and your doctor will carefully evaluate whether it's right for you. Certain medical conditions or situations make this medication potentially unsafe or less effective.

You shouldn't receive anifrolumab if you have a known severe allergic reaction to the medication or any of its components. Your doctor will also avoid this treatment if you have certain active infections, particularly serious bacterial, viral, or fungal infections that could worsen with immune system suppression.

People with significantly weakened immune systems from other causes may not be good candidates for anifrolumab. This includes patients with certain cancers, those taking high doses of other immunosuppressive medications, or individuals with inherited immune deficiencies.

Your doctor will also consider anifrolumab carefully if you have a history of recurrent serious infections, live virus vaccines received recently, or certain liver problems. Pregnancy and breastfeeding require special consideration, as the effects on developing babies aren't fully understood.

Additionally, if you have certain mental health conditions or a history of depression, your healthcare provider will monitor you extra closely, as some patients experience mood changes with this type of medication.

Anifrolumab Brand Name

Anifrolumab is marketed under the brand name Saphnelo in the United States and many other countries. This brand name helps distinguish it from other lupus medications and ensures you receive the correct treatment.

When discussing your treatment with healthcare providers or pharmacists, you can refer to your medication as either anifrolumab or Saphnelo. Both names refer to the same medication, though medical professionals often use the generic name anifrolumab in clinical discussions.

Your insurance coverage and treatment center may refer to the medication by either name, so it's helpful to know both. The packaging and infusion bags will clearly display the Saphnelo brand name along with the generic name anifrolumab.

Anifrolumab Alternatives

If anifrolumab isn't suitable for you or doesn't provide adequate symptom control, several alternative treatments exist for managing lupus. Your doctor can help you explore these options based on your specific symptoms and medical history.

Traditional lupus treatments include antimalarials like hydroxychloroquine, which many patients use as a foundation therapy. Immunosuppressive medications such as methotrexate, azathioprine, or mycophenolate can help control more severe symptoms.

Other biologic medications offer different approaches to lupus treatment. Belimumab (Benlysta) targets B-cells and has been available longer than anifrolumab. Rituximab, though used off-label for lupus, can be effective for certain patients with severe organ involvement.

Corticosteroids like prednisone provide rapid symptom relief but aren't ideal for long-term use due to side effects. Your doctor might use these medications to bridge you to other treatments or manage lupus flares.

Newer treatments continue to emerge, including other targeted therapies and combination approaches. Your rheumatologist stays current with these developments and can discuss which options might work best for your specific situation.

Is Anifrolumab Better Than Belimumab?

Comparing anifrolumab to belimumab isn't straightforward, as both medications work differently and may benefit different patients. The "better" choice depends on your specific lupus symptoms, medical history, and how you respond to treatment.

Anifrolumab targets type I interferons, while belimumab targets B-cells, two different parts of the immune system involved in lupus. Some patients respond better to one approach versus the other, and your doctor might even recommend using both medications together in certain situations.

Belimumab has been available longer and has more long-term safety data, which some patients and doctors prefer. However, anifrolumab may work better for patients with high interferon signatures, a specific laboratory finding that suggests this pathway is particularly active in their lupus.

Your rheumatologist considers multiple factors when choosing between these medications, including your kidney function, infection history, other medications you're taking, and your specific lupus manifestations. The decision often comes down to personalized medicine rather than one being universally superior.

Some patients try one medication first and switch to the other if the initial choice doesn't provide adequate benefit. This trial-and-error approach is common in lupus treatment, as the condition affects everyone differently.